AGREEMENT AND PLAN OF MERGER
Dated as of July 12, 2006
by and among
AVIVA PLC,
LIBRA ACQUISITION CORPORATION
and
AMERUS GROUP CO.
| Acquisition Proposal |
5.4(a) |
| Affected Employee |
5.7(a) |
| Agreement |
Preamble |
| AmerUs |
Preamble |
| AmerUs Actuarial
Analysis |
3.1(x)(ii) |
| AmerUs Adviser |
3.1(v)(iii) |
| AmerUs Benefit Plans |
3.1(j)(i) |
| AmerUs Board
Approval |
3.1(n) |
| AmerUs Broker-Dealer |
3.1(v)(iii) |
| AmerUs Contracts |
3.1(i) |
| AmerUs Current
Premium |
5.6(b) |
| AmerUs Disclosure
Letter |
3.1 |
| AmerUs Fund |
3.1(v)(iii) |
| AmerUs Insurance
Contracts |
3.1(x)(i) |
| AmerUs Insurer |
3.1(v)(iii) |
| AmerUs Intellectual
Property |
3.1(q)(i) |
| AmerUs Material
Adverse Effect |
3.1(a)(iv) |
| AmerUs Permits |
3.1(e)(i) |
| AmerUs PRIDES |
3.1(b)(ii) |
| AmerUs Private Fund |
3.1(v)(iii) |
| AmerUs Proposal |
7.2(b) |
| AmerUs Reinsurance
Agreements |
3.1(aa) |
| AmerUs Requisite
Regulatory Approvals |
6.2(c) |
| AmerUs SAP
Statements |
3.1(w)(i) |
| AmerUs SEC Documents |
3.1(d)(i) |
| AmerUs Shareholders
Meeting |
5.1(b) |
| AmerUs Stock Plans |
3.1(b)(i) |
| Annuity Contract |
3.1(h) |
| Articles of Merger |
1.2 |
| Aviva |
Preamble |
| Aviva Material
Adverse Effect |
3.2(a)(i) |
| Aviva Requisite
Regulatory Approvals |
6.3(c) |
| Award Consideration |
2.3 |
| Awards |
2.3 |
| Business Day |
1.3 |
| Change in AmerUs
Recommendation |
7.1(d) |
| Closing |
1.3 |
| Closing Date |
1.2 |
| Code |
2.2(g) |
| Common Stock |
2.1(a)(i) |
| Company Insiders |
5.11 |
| Confidentiality
Agreement |
5.2(b) |
| Effective Time |
1.2 |
| EI Products |
3.1(x)(iii) |
| ERISA |
3.1(j)(i) |
| Exchange Act |
3.1(c)(iii) |
| Exchange Agent |
2.2(a) |
| Exchange Period |
2.2(b) |
| GAAP |
3.1(a)(iv) |
| Governmental Entity |
3.1(c)(iii) |
| HSR Act |
3.1(c)(iii) |
| IBCA |
1.1 |
| Indemnified
Liabilities |
5.6(a) |
| Indemnified Parties |
5.6(a) |
| Interim AmerUs
Documents |
4.1(o) |
| Investment Advisers
Act |
3.1(v)(iii) |
| Investment Company
Act |
3.1(v)(ii) |
| Laws |
1.3 |
| Liens |
3.1(p) |
| Life Insurance
Contract |
3.1(h) |
| Merger |
Recitals |
| Merger Consideration |
2.1(a)(ii) |
| Merger Sub |
Preamble |
| Multiemployer Plans |
3.1(j)(i) |
| NASD |
3.1(c)(iii) |
| Notice of AmerUs
Shareholders Meeting |
3.1(u)(i) |
| Notice of Superior
Proposal |
7.1(e) |
| NYSE |
3.1(c)(iii) |
| Option |
2.3 |
| Option Consideration |
2.3 |
| Out-of-Pocket
Expenses |
7.2(b) |
| Per Share Amount |
2.1(a)(i) |
| Post Closing Plans |
5.7(c) |
| Producer |
3.1(z)(i) |
| Product Letter |
3.1(x)(iv) |
| Proxy Statement |
5.1(a) |
| Regulatory Material
Adverse Effect |
5.3(b) |
| Required AmerUs Vote |
3.1(o) |
| SAP |
3.1(a)(iv) |
| SAR |
2.3 |
| SAR Consideration |
2.3 |
| Sarbanes Oxley Act |
3.1(f)(i) |
| SEC |
3.1(a)(iv) |
| Securities Act |
3.1(d)(i) |
| separate account
shares |
3.1(b)(i) |
| Series A Preferred
Stock |
3.1(b)(i) |
| Subsidiary |
3.1(a)(iv) |
| Superior Proposal |
5.4(e) |
| Surviving
Corporation |
1.1 |
| Tax |
3.1(h) |
| Tax Asset |
3.1(h) |
| Tax Return |
3.1(h) |
| Tax Sharing
Agreement |
3.1(h) |
| Taxing Authority |
3.1(h) |
| Termination Fee |
7.2(b) |
| Transacted |
3.1(z)(i) |
| Unit |
2.3 |
| Unit Consideration |
2.3 |
| Violation |
3.1(c)(ii) |
| Voting Debt |
3.1(b)(ii) |
AGREEMENT AND PLAN OF MERGER dated as of July 12, 2006 (this ''Agreement''),
by and among AVIVA PLC, a company incorporated under the laws of England
and Wales with registration number 2468686 (''Aviva''), LIBRA
ACQUISITION CORPORATION, an Iowa corporation and an indirect wholly
owned subsidiary of Aviva (''Merger Sub''), and AMERUS GROUP CO.,
an Iowa corporation (''AmerUs'').
WHEREAS, the respective Boards of Directors of Aviva, AmerUs
and Merger Sub (and the Board of Directors of the appropriate Aviva
subsidiary as sole shareholder of Merger Sub) have approved and adopted
and deem it advisable and in the best interests of their respective
shareholders that the parties consummate the transactions contemplated
herein, upon the terms and subject to the conditions set forth herein
(the ''Merger'');
WHEREAS, the Board of Directors of AmerUs has resolved to
recommend to its shareholders approval and adoption of this Agreement
and the transactions contemplated hereby (including the Merger), upon
the terms and subject to the conditions set forth herein; and
WHEREAS, Aviva and AmerUs desire to make certain
representations, warranties and agreements in connection with the Merger
and also to prescribe various conditions to the Merger.
NOW, THEREFORE, in consideration of the foregoing and the
respective representations, warranties, covenants and agreements set
forth herein, the parties hereto agree as follows:
ARTICLE I
THE MERGER
1.1. The Merger. At the Effective Time and upon the
terms and subject to the conditions set forth herein and the Iowa
Business Corporation Act (the ''IBCA''), Merger Sub shall be merged
with and into AmerUs, the separate corporate existence of Merger Sub
shall cease, and AmerUs shall continue as the surviving corporation
(sometimes hereinafter referred to as the ''Surviving Corporation'').
1.2. Effective Time of the Merger. Subject to the
provisions of this Agreement and the requirements of Section 490.1106 of
the IBCA, articles of merger (the ''Articles of Merger'') shall be
duly prepared and executed by Merger Sub and AmerUs and thereafter
delivered to the Secretary of State of the State of Iowa as provided in
the IBCA. The Merger shall become effective upon the filing of the
Articles of Merger with the Secretary of State of the State of Iowa, or
at such time thereafter as is provided in the Articles of Merger (the ''Effective
Time'').
1.3. Closing. The closing of the Merger (the ''Closing'')
will take place at Noon, New York City Time, on the date that is the
second Business Day after the satisfaction or waiver (subject to any
applicable law, statute, ordinance, code, regulation, rule, judgment,
order, decree, injunction, arbitration award, decision or ruling of, any
Governmental Entity (''Laws'')) of the conditions set forth in
Article VI (excluding conditions that, by their terms, are to be
satisfied on the Closing Date), unless another time or date is agreed to
in writing by the parties hereto (the actual date and time of the
Closing are herein referred to as the ''Closing Date'') . The
Closing shall be held at the [[Page 1]]
offices of LeBoeuf, Lamb, Greene & MacRae LLP, in New York, New York,
unless another place is agreed to in writing by the parties hereto. ''Business
Day''as used herein shall mean any day other than a Saturday, Sunday
or other day on which banking institutions in New York or Iowa are
obligated by Law or executive order to be closed.
1.4. Effects of the Merger. At the Effective Time, the
effect of the Merger shall be as provided in this Agreement and the
applicable provisions of the IBCA. Without limiting the generality of
the foregoing, and subject thereto, at the Effective Time all the
property, rights, privileges, powers and franchises of AmerUs and Merger
Sub shall vest in the Surviving Corporation, and all debts, liabilities
and duties of AmerUs and Merger Sub shall become the debts, liabilities
and duties of the Surviving Corporation.
1.5. Articles of Incorporation and Bylaws of Surviving
Corporation. The Articles of Incorporation of AmerUs as in effect
immediately prior to the Effective Time shall be the Articles of
Incorporation of the Surviving Corporation. The Bylaws of Merger Sub as
in effect immediately prior to the Effective Time, as set forth in
Exhibit A hereto, shall be the Bylaws of the Surviving Corporation.
1.6. Directors and Officers of the Surviving Corporation.
The directors of Merger Sub immediately prior to the Effective Time
shall be the directors of the Surviving Corporation; provided that the
President and Chief Executive Officer of AmerUs shall be a director of
the Surviving Corporation, with each director holding office until the
next annual meeting (or the earlier of their resignation or removal) and
until their respective successors are duly elected and qualified, as the
case may be. The officers of AmerUs immediately prior to the Effective
Time shall be the officers of the Surviving Corporation until the
earlier of their resignation or removal or until their respective
successors are duly appointed and qualified, as the case may be.
1.7. Subsequent Actions. If, at any time after the
Effective Time, the Surviving Corporation shall consider or be advised
that any deeds, bills of sale, assignments, assurances or any other
actions or things are necessary or desirable to vest, perfect or confirm
of record or otherwise in the Surviving Corporation its right, title or
interest in, to or under any of the rights, properties or assets of
either of AmerUs or Merger Sub acquired or to be acquired by the
Surviving Corporation as result of, or in connection with, the Merger or
otherwise to carry out the terms of this Agreement, the officers and
directors of the Surviving Corporation shall be authorized to execute
and deliver, in the name and on behalf of either AmerUs or Merger Sub,
all such deeds, bills of sale, assignments and assurances and to take
and do, in the name and on behalf of each of such corporation, all such
other actions and things as may be necessary or desirable to vest,
perfect or confirm any and all right, title and interest in, to and
under such rights, properties or assets in the Surviving Corporation or
otherwise to carry out the terms of this Agreement, in accordance with
the requirements of the IBCA. [[Page 2]]
ARTICLE II
TREATMENT OF SHARES
2.1. Conversion of Securities. As of the Effective
Time, by virtue of the Merger and without any action on the part of
Merger Sub, AmerUs or the holder of any of the following securities:
(a) Conversion of AmerUs Capital Stock. Each share of AmerUs
Common Stock, no par value (the ''Common Stock''), issued and
outstanding immediately prior to the Effective Time (other than any
shares of Common Stock to be canceled pursuant to Section 2.1(b)) shall
be cancelled and extinguished and be converted into the right to receive
$69.00 (the ''Per Share Amount'') in cash payable to the holder
thereof, without interest, upon surrender of the certificate or
certificates representing such Common Stock. The cash into which the
shares of Common Stock and outstanding Awards, as set forth in
Section 2.3, are to be exchanged is referred to herein as the ''Merger
Consideration.''
(b) Cancellation of Treasury Stock. Each share of Common
Stock held in the treasury of AmerUs and each share of Common Stock
owned by any direct or indirect Subsidiary of AmerUs (other than, for
the avoidance of doubt, separate account shares, as such term is defined
in Section 3.1(b)) immediately prior to the Effective Time shall be
canceled and extinguished, and no payment or other consideration shall
be made with respect thereto.
(c) Conversion of Merger Sub Capital Stock. Each share of
common stock, no par value, of Merger Sub issued and outstanding
immediately prior to the Effective Time shall thereafter represent one
validly issued, fully paid and nonassessable share of common stock, no
par value, of the Surviving Corporation with the same rights, powers and
privileges as the share so converted, and the shares so converted shall
constitute the only outstanding shares of capital stock of the Surviving
Corporation.
2.2. Surrender of Capital Stock; Stock Transfer Books.
(a) Exchange Agent. Prior to the Effective Time, Aviva shall
designate at its own cost and expense a bank or trust company
(reasonably acceptable to AmerUs) to act as agent for the holders of
Common Stock (the ''Exchange Agent'') to receive the funds
necessary to make the payments contemplated by Sections 2.1 and 2.3. At
or prior to the Effective Time, Aviva shall deposit, or cause to be
deposited, in trust with the Exchange Agent for the benefit of holders
of Common Stock, the aggregate consideration to which such holders shall
be entitled to at the Effective Time pursuant to Sections 2.1 and 2.3.
(b) Exchange Period. Each holder of a certificate or
certificates representing any shares of Common Stock canceled upon the
Merger pursuant to Section 2.1(a) may thereafter surrender such
certificates or certificates to the Exchange Agent as agent for such
holder, to effect the surrender of such certificate or certificates on
such holders behalf for a period ending one year after the Effective
Time (the ''Exchange Period''). Aviva agrees that promptly after
the Effective Time it shall cause the distribution to holders of record
of shares of Common Stock as of the Effective Time of appropriate
materials, including a letter of transmittal, to facilitate such [[Page 3]]
surrender, which materials shall be reasonably acceptable to AmerUs.
Upon the surrender of certificates representing the Common Stock, Aviva
shall cause the Exchange Agent to pay the holder of such certificates in
exchange therefor cash in an amount equal to the Per Share Amount
multiplied by the number of shares of Common Stock, plus the amount of
dividends or other distributions with a record date prior to the
Effective Time, if any, remaining unpaid with respect to the Common
Stock, represented by such certificate immediately prior to the
Effective Time. Until so surrendered, each such certificate (other than
certificates representing Common Stock canceled pursuant to
Section 2.1(b)) shall represent solely the right to receive the
aggregate Per Share Amount, relating thereto, subject however to Avivas
obligation (if any) to pay any dividends or make any other distributions
with a record date prior to the Effective Time which may have been
declared by AmerUs on the shares of Common Stock, in accordance with the
terms of this Agreement or prior to the date of this Agreement and which
remain unpaid at the Effective Time.
(c) Payment to Other Persons. If payment of cash in respect
of canceled shares of Common Stock is to be made to a person other than
the person in whose name a surrendered certificate or instrument is
registered, it shall be a condition to such payment that the certificate
or instrument so surrendered shall be properly endorsed or shall be
otherwise in proper form for transfer and that the person requesting
such payment shall have paid any transfer and other taxes required by
reason of such payment in a name other than that of the registered
holder of the certificate or instrument surrendered or shall have
established to the satisfaction of Aviva or the Exchange Agent that such
tax is not payable.
(d) Transfer Books. At the Effective Time, the stock
transfer books of AmerUs shall be closed and there shall not be any
further registration or transfer of any shares of Common Stock
thereafter on the records of AmerUs. If, after the Effective Time,
certificates for shares of Common Stock are presented to the Surviving
Corporation they shall be cancelled and exchanged for cash as provided
in Section 2.1(a). No interest shall accrue or be paid on any cash
payable upon the surrender of a certificate or certificates which
immediately prior to the Effective Time represented outstanding shares
of Common Stock.
(e) Lost, Stolen or Destroyed Certificates. In the event any
certificates representing Common Stock shall have been lost, stolen or
destroyed, the Exchange Agent shall issue in exchange for such lost,
stolen or destroyed certificates, upon the making of an affidavit of
that fact by the holder thereof, the Per Share Amount and any dividends
or other distributions as may be required pursuant to this Article II in
respect of the shares of Common Stock represented by such lost, stolen
or destroyed certificates; provided, however, that Aviva
may, in its reasonable discretion and as a condition precedent to the
issuance thereof, require the owner of such lost, stolen or destroyed
certificates to enter into an indemnity agreement with respect to any
claim that may be made against Aviva or the Exchange Agent with respect
to the certificates alleged to have been lost, stolen or destroyed.
(f) Conclusion of Exchange Period. Promptly following the
expiration of the Exchange Period, subject to applicable Law, the
Exchange Agent shall deliver to Aviva all cash (including any interest
received with respect thereto), certificates and other documents in its
possession relating to the transactions contemplated hereby, and the
Exchange Agents duties shall terminate. Thereafter, each holder of
(i) a certificate representing Common Stock (other [[Page 4]]
than certificates representing Common Stock canceled pursuant to
Section 2.1(b)), or (ii) an Award shall be entitled to look to the
Surviving Corporation with respect to the aggregate Per Share Amount or
the aggregate Award Consideration, as applicable, payable upon due
surrender of their certificates by holders of certificates, and payable
as soon as practicable to holders of Awards, without any interest
thereon. Notwithstanding the foregoing, subject to applicable Law,
neither Aviva, the Surviving Corporation nor the Exchange Agent shall be
liable to any holder of a certificate representing Common Stock or any
holder of an Award for any amount delivered to a public official
pursuant to any applicable abandoned property, escheat or similar Law.
Any portion of the Merger Consideration remaining unclaimed by holders
of Common Stock or Award as of a date that is immediately prior to such
time as such amounts would otherwise escheat to or become property of
any Governmental Entity shall, to the extent permitted by applicable
Law, become the property of the Surviving Corporation free and clear of
any claims or interest of any person previously entitled thereto.
(g) Withholdings. Notwithstanding any provision in this
Agreement to the contrary, AmerUs, its Subsidiaries and Aviva shall
cooperate with each other and take all reasonably necessary steps
between the date hereof and the Effective Time to determine if any
amounts should be withheld or deducted from any payments made under this
Agreement pursuant to the Internal Revenue Code of 1986, as amended
(including all rules and regulations promulgated thereunder, the ''Code''),
or under any provision of any state, county, local or foreign tax Law,
including Section 1445 of the Code. The Per Share Amount and the Award
Consideration paid in the Merger shall be subject to reduction for any
applicable withholding Taxes or, as set forth in Section 2.2(c), stock
transfer taxes payable by such holder. To the extent that amounts are so
withheld by Aviva, AmerUs or the Exchange Agent, such withheld amounts
shall be treated for all purposes of this Agreement as having been paid
to the holder of the relevant shares.
(h) Certain Adjustments. If, between the date of this
Agreement and the Effective Time, the outstanding Common Stock shall
have been changed into a different number of shares or different class
by reason of any reclassification, recapitalization, stock split,
split-up, combination or exchange of shares or a stock dividend or
dividend payable in any other securities shall be declared with a record
date within such period, or any similar event shall have occurred, the
Merger Consideration shall be equitably adjusted to eliminate the
effects of such event.
2.3. AmerUs Stock Awards. The right to receive shares
of Common Stock pursuant to the exercise of each vested and unvested
option for Common Stock (each, an ''Option'') that is outstanding
immediately prior to the Effective Time shall be converted into the
right to receive an amount of cash per share subject to the Option equal
to the product obtained by multiplying (x) the total number of shares of
Common Stock issuable upon the exercise in full of such Options by (y)
the excess, if any, of the amount of the Per Share Amount over the
exercise price per share of Common Stock under such Option (with the
aggregate amount of such payment rounded up to the nearest cent), less
any required withholding taxes (the ''Option Consideration''). The
right to receive a share of Common Stock or cash value equal to the
value thereof pursuant to each vested and unvested stock unit,
performance unit or similar award (each, a ''Unit'') that is
outstanding immediately prior to the Effective Time (excluding any stock
unit to which a stock appreciation right relates and provided
that any unvested performance unit or similar award that vests shall do
so at its ''target''level) shall be converted into the right to receive
an amount of cash per Unit equal to [[Page 5]]
2.the amount of the Per Share Amount (with the aggregate amount of the
payment for all Units rounded up to the nearest cent), less any required
withholding taxes (such aggregate amount, the ''Unit Consideration'').
The right to receive shares of Common Stock or cash pursuant to the
exercise of each vested and unvested stock appreciation right (each, a ''SAR'')
that is outstanding immediately prior to the Effective Time shall be
converted into the right to receive an amount of cash per stock unit to
which the SAR relates equal to the product obtained by multiplying
(x) the total number of unexercised stock units to which the SAR relates
by (y) the excess, if any, of the amount of the Per Share Amount over
the fair market value of a share of Common Stock on the SARs date of
grant (with the aggregate amount of the payment for all such SAR stock
units rounded up to the nearest cent), less any required withholding
taxes (such aggregate amount, the ''SAR Consideration,''and
together with the Option Consideration and Unit Consideration, the ''Award
Consideration''). As of the Effective Time, all such Options, Units
and SARs (together, ''Awards'') shall no longer be outstanding and
shall automatically be canceled and retired and shall expire and cease
to exist and each holder of such Awards shall cease to have any rights
with respect thereto, except the right to receive the Award
Consideration without interest. Aviva agrees that AmerUs may amend the
AmerUs Stock Plans as necessary for the sole purpose of implementing the
foregoing provisions of this Section 2.3; provided, however,
prior to any amendment AmerUs consults with Aviva as to, and provides
Aviva with a copy of, the terms of any such proposed amendment. The cash
amounts resulting from the conversions pursuant to this Section 2.3
shall be paid as soon as practicable after the Effective Time, but no
later than five Business Days thereafter.
ARTICLE III
REPRESENTATIONS AND WARRANTIES
3.1. Representations and Warranties of AmerUs. Except
as set forth in (x) the written disclosure letter delivered by AmerUs to
Aviva in connection with the execution and delivery of this Agreement
(the ''AmerUs Disclosure Letter''), it being acknowledged and
agreed by Aviva that any matter set forth in any section or subsection
of the AmerUs Disclosure Letter shall be deemed to be a disclosure for
all purposes of this Agreement and all other sections or subsections of
the AmerUs Disclosure Letter to where it is readily apparent that the
matters so disclosed are applicable, but shall expressly not be deemed
to constitute an admission by AmerUs or any of its Subsidiaries, or
otherwise imply, that any such matter rises to the level of an AmerUs
Material Adverse Effect or is otherwise material for purposes of this
Agreement or the AmerUs Disclosure Letter or (y) any AmerUs SEC
Documents filed or furnished and made publicly available prior to the
date of this Agreement (excluding any disclosures set forth in any such
SEC Documents under the headings ''Safe Harbor Statement'',''Risk Factors''or any similar sections and any disclosures of risks included therein
that are predictive or forward looking in nature), AmerUs represents and
warrants to Aviva and Merger Sub as follows:
(a) Organization, Standing and Power.
(i) Each of AmerUs and its Subsidiaries is a corporation duly
organized and validly existing and in good standing (except in the case
of AmerUs and each Subsidiary incorporated under the laws of the State
of Iowa, in which case each shall be considered to be in good standing
if they are validly existing) under the Laws of its jurisdiction of
incorporation, has all requisite power and authority to own, lease and
operate its properties and to carry on its
[[Page 6]]
business as now being conducted, and is duly qualified to do business in
each jurisdiction in which the nature of its business or the ownership
or leasing of its properties makes such qualification necessary, other
than in such jurisdictions where the failure to so qualify would not,
either individually or in the aggregate, reasonably be expected to have
an AmerUs Material Adverse Effect.
(ii) The copies of the Amended and Restated Articles of
Incorporation and Amended and Restated Bylaws of AmerUs incorporated by
reference in the Form 10-K of AmerUs for the fiscal year ended
December 31, 2005 are true, complete and correct copies of such
documents, are in full force and effect and have not been amended or
otherwise modified. AmerUs is not in material violation of any provision
of its Amended and Restated Articles of Incorporation or its Amended and
Restated Bylaws, and no Subsidiary of AmerUs is in material violation of
any provision of its articles of incorporation, bylaws or equivalent
organizational documents.
(iii) AmerUs has made available to Aviva complete and correct
copies (except as redacted to protect confidential information related
to the transactions contemplated by this Agreement or other alternative
strategic transactions considered since July 1, 2004) of the minutes
(or, in the case of minutes that have not yet been finalized, drafts
thereof) of all meetings of the shareholders of AmerUs and the Board of
Directors of AmerUs, in each case held since January 1, 2003 and prior
to the date hereof.
(iv) As used in this Agreement: (x) the word ''Subsidiary''when used with respect to any party means any entity of which 50% or
more of the effective voting power or equity or other ownership interest
of such entity is directly or indirectly owned by such party; provided that the term ''Subsidiary''shall not include any
corporation, general or limited partnership, limited liability company,
joint venture, trust or other entity created or organized and currently
existing for the sole purpose of acquiring, constructing, developing,
improving, owning, maintaining, operating, managing or otherwise dealing
with real estate assets included in AmerUs investment portfolio; and
(y) the term ''AmerUs Material Adverse Effect''means, with respect
to AmerUs or any of its Subsidiaries, an event, change, circumstance,
state of facts or effect, alone or in combination, that has had or is
reasonably likely to have a material adverse effect on (A) the financial
condition, properties, assets, liabilities, businesses or results of
operations (excluding the impact of non-recurring events on results of
operations in the period in which such events occur) of AmerUs and its
Subsidiaries, taken as a whole, except to the extent that any such
material adverse effect results, alone or in combination, from
(1) changes in the economy in general in the United States; (2) changes
in United States or global financial or securities markets or
conditions, including those caused by natural catastrophes, acts of war,
hostility or terrorism; (3) changes in the life insurance and annuity
industries generally (excluding changes in applicable Laws), to the
extent such changes do not have a materially disproportionate effect on
AmerUs or any of its Subsidiaries; (4) changes in applicable Law or
releases, or the adoption, modification or interpretation by the SEC of
any Laws or releases, in each case relating to annuities and life
insurance contracts offering equity index strategies or total return
accounts, including EI Products; (5) changes in United States generally
accepted accounting principles or in statutory accounting practices
after the date of this Agreement prescribed or permitted by the
applicable domiciliary state regulation, in each case applied on a
consistent basis during the periods involved (except as may be disclosed
therein) (''GAAP''or [[Page 7]]
''SAP,''respectively), including accounting pronouncements by the
Securities and Exchange Commission (the ''SEC''), the National
Association of Insurance Commissioners and the Financial Accounting
Standards Board; (6) any adverse development after the date hereof in
the pending litigations, mediations, arbitrations and regulatory
investigations, inquiries and proceedings set forth on Section 3.1(g) of
the AmerUs Disclosure Letter, other than any such development that,
considered in the aggregate with all other adverse or positive
developments relating to such litigations, mediations, arbitrations and
regulatory investigations, inquiries and proceedings, would materially
increase the reasonably anticipated economic impact to AmerUs and its
Subsidiaries, taken as a whole, of the disposition of such litigations,
mediations, arbitrations and regulatory investigations, inquiries and
proceedings compared to the reasonable expectations of the parties of
such economic impact as of the date hereof; or (7) the execution,
delivery and performance of this Agreement or the announcement of the
transactions contemplated hereby, including the identity of Aviva, or
(B) the ability of AmerUs to perform its obligations hereunder on a
timely basis.
(b) Capital Structure.
(i) The authorized capital stock of AmerUs consists of two
hundred and thirty million (230,000,000) shares of Common Stock and
twenty million (20,000,000) shares of preferred stock, no par value. The
only authorized series of AmerUs preferred stock is the Series A
Non-Cumulative Perpetual Preferred Stock (the ''Series A Preferred
Stock'').
(ii) As of the close of business on July 7, 2006,
(A) 38,140,526 shares of Common Stock were issued and outstanding,
(B) 3,223,441 shares of Common Stock were reserved for issuance upon the
exercise or payment of outstanding stock options, stock units or other
awards (such stock options, units and other awards and plans and
programs, collectively, the ''AmerUs Stock Plans''), and
(C) 8,806,966 shares of Common Stock were held in the treasury of AmerUs
or by its Subsidiaries (exclusive of shares held in insurance company
separate accounts (any such shares, ''separate account shares'').
From July 7, 2006 to the date hereof, AmerUs has not issued or permitted
to be issued any shares of capital stock, SARs or securities exercisable
or exchangeable for or convertible into shares of capital stock of
AmerUs or any of its Subsidiaries, other than pursuant to and as
required by the terms of the AmerUs Stock Plans and, from July 7, 2006
to the date hereof, AmerUs has not issued any stock options or other
awards under the AmerUs Stock Plans. As of the close of business on
July 7, 2006, six million (6,000,000) shares of Series A Preferred Stock
were issued and outstanding. No shares of Series A Preferred Stock are
reserved for issuance. All outstanding shares of Common Stock and
Series A Preferred Stock have been duly authorized and validly issued
and are fully paid and non-assessable and not subject to preemptive
rights. As of the close of business on July 7, 2006, 5,750,000 PRIDES
Securities offered by AmerUs pursuant to the prospectus supplement dated
May 21, 2003 (the ''AmerUs PRIDES'') were issued and outstanding.
(iii) No bonds, debentures, notes or other indebtedness having
the right to vote on any matters on which shareholders may vote (''Voting
Debt'') of AmerUs or any Subsidiary of AmerUs are issued or
outstanding.
(iv) Except for (A) Awards issued or to be issued under the
AmerUs Stock Plans and (B) Common Stock purchase rights issued in
connection with the AmerUs PRIDES,
[[Page 8]]
there are no options, warrants, calls, convertible or exchangeable
securities, rights, commitments or agreements of any character to which
AmerUs or any Subsidiary of AmerUs is a party or by which it or any such
Subsidiary is bound (x) obligating AmerUs or any Subsidiary of AmerUs to
issue, deliver or sell, or cause to be issued, delivered or sold,
additional shares of capital stock or any Voting Debt or stock
appreciation rights of AmerUs or of any Subsidiary of AmerUs,
(y) obligating AmerUs or any Subsidiary of AmerUs to grant, extend or
enter into any such option, warrant, call, convertible or exchangeable
security, right, commitment or agreement or (z) which provide the
economic equivalent of an equity ownership interest in AmerUs or any
Subsidiary of AmerUs. There are no outstanding contractual obligations
of AmerUs or any of its Subsidiaries to repurchase, redeem or otherwise
acquire any shares of capital stock of AmerUs or any of its
Subsidiaries. None of AmerUs or any Subsidiary of AmerUs is a party to
any shareholders agreement, voting trust agreement or registration
rights agreement relating to any equity securities of AmerUs or any
Subsidiary of AmerUs or any other agreement relating to disposition,
voting or dividends with respect to any equity securities of AmerUs or
any Subsidiary of AmerUs.
(v) Since June 30, 2006, AmerUs has not declared, set aside,
made or paid to the shareholders of AmerUs dividends or other
distributions on the outstanding shares of Common Stock or Series A
Preferred Stock, other than regular quarterly cash dividends on the
Series A Preferred Stock.
(c) Authority.
(i) AmerUs has all requisite corporate power and authority to
enter into this Agreement and, subject in the case of the consummation
of the Merger to the approval of this Agreement by the requisite vote of
the holders of Common Stock, to consummate the transactions contemplated
hereby. The execution and delivery of this Agreement and the
consummation of the transactions contemplated hereby have been duly
authorized by all necessary corporate action on the part of AmerUs and
no other corporate proceedings on the part of AmerUs are necessary to
authorize this Agreement and consummate the transactions contemplated
hereby, subject in the case of the consummation of the Merger to the
approval of this Agreement by the shareholders of AmerUs. This Agreement
has been duly executed and delivered by AmerUs and (assuming the due
authorization, execution and delivery by Aviva and Merger Sub)
constitutes a valid and binding obligation of AmerUs, enforceable
against AmerUs in accordance with its terms, except to the extent
enforcement is limited by bankruptcy, insolvency, fraudulent transfer,
reorganization, moratorium and similar Laws of general applicability
relating to or affecting creditors rights and to general equitable
principles.
(ii) The execution and delivery of this Agreement do not, and
the performance of its obligations and consummation of the transactions
contemplated hereby will not, (A) conflict with, or result in any
violation of, or constitute a default (with or without notice or lapse
of time, or both) under, or give rise to a right of termination,
cancellation or acceleration of any obligation or the loss of a material
benefit under, or the creation of a lien, pledge, security interest,
charge or other encumbrance on any assets (any such conflict, violation,
default, right of termination, cancellation or acceleration, loss or
creation, a ''Violation'') pursuant to any provision of the Amended
and Restated Articles of Incorporation or Amended and Restated Bylaws of
AmerUs or the Articles of Incorporation or Bylaws of any Subsidiary of
AmerUs, or [[Page 9]]
(B) subject to obtaining or making the consents, approvals, orders,
authorizations, registrations, declarations and filings referred to in
subsection (iii) below, result in any Violation of any loan or credit
agreement, note, mortgage, indenture, lease, treaty, AmerUs Benefit Plan
or other agreement, obligation, instrument, permit, concession,
franchise, license, judgment, order, decree, statute, Law, ordinance,
rule or regulation applicable to AmerUs or any Subsidiary of AmerUs or
their respective properties or assets, which Violation, in the case of
clause (B), either individually or in the aggregate, would reasonably be
expected to have an AmerUs Material Adverse Effect.
(iii) No consent, approval, order or authorization of, or
registration, declaration or filing with, any court, administrative
agency or commission or other governmental authority or instrumentality,
domestic or foreign, arbitral tribunal, or industry self-regulatory
organization (each, a ''Governmental Entity''), is required to be
filed or obtained by AmerUs or any of its Subsidiaries (as opposed to
Aviva or Merger Sub or any of their respective affiliates) in order for
AmerUs to (x) execute and deliver this Agreement or (y) consummate the
Merger, which the failure to make or obtain, individually or in the
aggregate, would reasonably be expected to have an AmerUs Material
Adverse Effect, except for (A) the filing with the SEC of such
statements, prospectuses, reports and other materials, including,
(1) the Proxy Statement, and (2) such reports, filings and statements
under the Securities Exchange Act of 1934, as amended (the ''Exchange
Act'') as may be required in connection with this Agreement and the
Merger, (B) the filing of the Articles of Merger with the Secretary of
State of the State of Iowa, (C) consents, authorizations, approvals,
filings or exemptions as set forth in Section 3.1(c)(iii) of the AmerUs
Disclosure Letter, (D) notices or filings under the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended (the ''HSR Act''),
(E) compliance with any applicable requirements of the New York Stock
Exchange (the ''NYSE'') and (F) consents, authorizations,
approvals, filings or exemptions in connection with compliance with the
applicable provisions of state and federal securities laws relating to
the regulation of broker-dealers, investment companies and investment
advisers and the rules and regulations of the National Association of
Securities Dealers, Inc. (the ''NASD''). Section 3.1(c)(iii) of the
AmerUs Disclosure Letter sets forth a complete list of the jurisdictions
in which each of the AmerUs Insurers are domiciled or commercially
domiciled.
(d) SEC Documents; Regulatory Reports; Undisclosed Liabilities.
(i) AmerUs and its Subsidiaries, including the AmerUs Insurers
and their respective separate accounts, have filed or furnished all
required reports, schedules, registration statements and other documents
and exhibits thereto with or to the SEC since December 31, 2003 and
through the Business Day prior to the date of this Agreement (the ''AmerUs
SEC Documents''). As of their respective dates of filing with or
publicly furnishing to the SEC (or, if amended or supplemented by a
filing prior to the date hereof, as of the date of such latest filing),
the AmerUs SEC Documents complied in all material respects with the
requirements of the Securities Act of 1933, as amended (the ''Securities
Act''), or the Exchange Act, as the case may be, and the rules and
regulations of the SEC thereunder applicable to such AmerUs SEC
Documents, and none of the AmerUs SEC Documents when filed with or
publicly furnished to the SEC (or, if amended or supplemented by a
filing prior to the date hereof, as of the date of such latest filing)
contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were
made, not misleading. The financial statements of [[Page 10]]
AmerUs and its Subsidiaries, including the AmerUs Insurers and their
respective registered separate accounts, included in the AmerUs SEC
Documents complied, as of their respective dates of filing with the SEC
(or, if amended or supplemented by a filing prior to the date hereof, as
of the date of such latest filing), in all material respects with all
applicable accounting requirements and with the published rules and
regulations of the SEC with respect thereto, have been prepared in
accordance with GAAP and fairly present in all material respects the
consolidated financial position of AmerUs and its consolidated
Subsidiaries (in the case of AmerUs SEC Documents filed by AmerUs) or
the entities purported to be presented therein (in the case of AmerUs
SEC Documents filed by Subsidiaries or separate accounts) and the
consolidated results of operations, changes in shareholders equity and
cash flows of such companies or entities as of the dates and for the
periods shown (subject, in the case of any unaudited interim financial
statements, to normal and recurring year-end adjustments that,
individually or in the aggregate, would not reasonably be expected to
have an AmerUs Material Adverse Effect).
(ii) Other than the AmerUs SEC Documents, which are addressed
in clause (i) above, AmerUs and each of its Subsidiaries, including the
AmerUs Insurers and their separate accounts, have timely filed (after
taking into account all grace periods or extensions) all reports,
registrations and statements, together with any amendments required to
be made with respect thereto, that they were required to file since
December 31, 2003 with any Governmental Entity, and have paid all fees
and assessments due and payable in connection therewith, except where
the failure to file such report, registration or statement or to pay
such fees and assessments would not reasonably be expected to have,
either individually or in the aggregate, an AmerUs Material Adverse
Effect.
(iii) Except for (A) those liabilities that are fully
reflected or reserved for in the consolidated financial statements of
AmerUs included in its Quarterly Report on Form 10-Q for the quarter
ended March 31, 2006, as filed with the SEC prior to the date of this
Agreement, (B) liabilities incurred since March 31, 2006 in the ordinary
course of business consistent with past practice, (C) liabilities
incurred pursuant to this Agreement and the transactions contemplated
hereby and (D) liabilities which would not, individually or in the
aggregate, reasonably be expected to have an AmerUs Material Adverse
Effect, AmerUs and its Subsidiaries do not have, and since March 31,
2006, AmerUs and its Subsidiaries have not incurred, any liabilities or
obligations of any nature whatsoever (whether accrued, absolute,
contingent or otherwise and whether or not required to be reflected in
AmerUs financial statements in accordance with generally accepted
accounting principles).
(e) Compliance with Applicable Laws and Reporting Requirements.
AmerUs and its Subsidiaries hold all permits, licenses, variances,
exemptions, orders and approvals of all Governmental Entities which are
required for the operation of the businesses of AmerUs and its
Subsidiaries (the ''AmerUs Permits''), and AmerUs and its
Subsidiaries are in compliance with the terms of the AmerUs Permits and
all applicable Laws, except where the failure to so hold or comply,
individually or in the aggregate, would not reasonably be expected to
have an AmerUs Material Adverse Effect. The businesses of AmerUs and its
Subsidiaries are not being conducted in violation of any Law, except for
possible violations which, individually or in the aggregate, do not
have, and would not reasonably be expected to have, an AmerUs Material
Adverse Effect. AmerUs has not received any written notice of a pending
investigation by any [[Page 11]]
Governmental Entity with respect to AmerUs or any of its Subsidiaries
nor, to the knowledge of AmerUs, is any such investigation threatened,
other than, in each case, those the outcome of which, individually or in
the aggregate, would not reasonably be expected to have an AmerUs
Material Adverse Effect.
(f) Sarbanes Oxley Act.
(i) AmerUs and its Subsidiaries are in compliance with (A) the
applicable provisions of the Sarbanes-Oxley Act of 2002 and the related
rules and regulations promulgated thereunder or under the Exchange Act
(the ''Sarbanes Oxley Act'') and (B) the applicable listing and
corporate governance rules and regulations of the NYSE, except where the
failure to so comply, individually or in the aggregate, would not
reasonably be expected to have an AmerUs Material Adverse Effect. Except
as permitted by the Exchange Act, including Section 13(k)(2) and (3),
since the enactment of the Sarbanes-Oxley Act, neither AmerUs, its
Subsidiaries nor any of its affiliates has made, arranged or modified
(in any material way) personal loans to any executive officer or
director of AmerUs or any of its Subsidiaries.
(ii) The Chief Executive Officer and Chief Financial Officer
of AmerUs (or each former Chief Executive Officer and Chief Financial
Officer of AmerUs, as applicable) have made all certifications required
by Rule 13a-14 or 15(d) under the Exchange Act or Sections 302 and 906
of the Sarbanes-Oxley Act and the rules and regulations of the SEC
promulgated thereunder with respect to AmerUs SEC Documents. AmerUs has
made available to Aviva a summary of any disclosure made by the
management of AmerUs to AmerUs independent auditors and the audit
committee of the Board of Directors of AmerUs since December 31, 2003
referred to in such certificates.
(iii) The management of AmerUs has (A) designed and
implemented disclosure controls and procedures (as defined in
Rule 13a-15(e) of the Exchange Act), or caused such disclosure controls
and procedures to be designed and implemented under their supervision,
to ensure that material information relating to AmerUs, including its
Subsidiaries, is made known to management of AmerUs by others within
those entities and (B) has disclosed, based on its most recent
evaluation of internal control over financial reporting (as defined in
Rule 13a-15(f) of the Exchange Act), to AmerUs outside auditors and the
audit committee of the Board of Directors of AmerUs (1) any significant
deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which could reasonably be
expected to adversely affect AmerUs ability to record, process,
summarize and report financial information and (2) any fraud, whether or
not material, that involves management or other employees who have a
significant role in AmerUs internal control over financial reporting.
Since December 31, 2005, any material change in internal control over
financial report required to be disclosed in any AmerUs SEC Document has
been so disclosed.
(iv) Since December 31, 2005 (i) neither AmerUs nor any of its
Subsidiaries nor, to the knowledge of AmerUs, any representative of
AmerUs or any of its Subsidiaries has received or otherwise obtained
knowledge of any material complaint, allegation, assertion or claim,
whether written or oral, regarding the accounting or auditing practices,
procedures, methodologies or methods of AmerUs or any of its
Subsidiaries or their respective internal accounting controls relating
to periods after December 31, 2005, including any material [[Page 12]]
complaint, allegation, assertion or claim that AmerUs or any of its
Subsidiaries has engaged in questionable accounting or auditing
practices (except for any of the foregoing received after the date of
this Agreement which have no reasonable basis), and (ii) to the
knowledge of AmerUs, no attorney representing AmerUs or any of its
Subsidiaries, whether or not employed by AmerUs or its Subsidiaries, has
reported evidence of a material violation of securities law, breach of
fiduciary duty or similar violation, relating to periods after
December 31, 2005, by AmerUs or any of its officers, directors,
employees or agents of AmerUs to the Board of Directors of AmerUs or any
committee thereof or to any director or executive officer of AmerUs.
(g) Legal Proceedings. There are no suits, actions,
investigations or proceedings (whether judicial, arbitral,
administrative or other) pending or, to the knowledge of AmerUs,
threatened, against or affecting AmerUs or any Subsidiary of AmerUs,
that, individually or in the aggregate, would reasonably be expected to
have an AmerUs Material Adverse Effect, nor are there any judgments,
decrees, injunctions, rules or orders of any Governmental Entity
outstanding against AmerUs or any Subsidiary of AmerUs having or which
would reasonably be expected to have, individually or in the aggregate,
an AmerUs Material Adverse Effect.
(h) Taxes.
(i) All material Tax Returns required by applicable Law to be
filed with any Taxing Authority by, or on behalf of, AmerUs or any of
its Subsidiaries have been filed in the manner and within the time
prescribed by applicable Law, and all such Tax Returns were, or shall be
at the time of filing, true and complete in all material respects.
(ii) There are no material liens for any Taxes upon the assets
of AmerUs or any of its Subsidiaries, other than (A) statutory liens for
Taxes not yet due and payable or (B) liens which are being contested in
good faith by appropriate proceedings and have been disclosed in writing
to Aviva as of the date hereof.
(iii) AmerUs and each of its Subsidiaries has paid (or has had
paid on its behalf) or has withheld and remitted to the appropriate
Taxing Authority all material Taxes due and payable, or has established
(or has had established on its behalf and for its sole benefit and
recourse), in accordance with GAAP, an accurate and sufficient accrual
for all such Taxes on the consolidated financial statements of AmerUs
included in its Quarterly Report on Form 10-Q for the quarter ended
March 31, 2006, as filed with the SEC prior to the date of this
Agreement.
(iv) The federal income Tax Returns of AmerUs and its
Subsidiaries through the tax year ended December 31, 2003, have been
examined and closed or are Tax Returns with respect to which the
applicable period for assessment under applicable Law, after giving
effect to granted extensions or waivers, has expired.
(v) There is no claim, audit, action, suit, proceeding or
investigation now in process, pending or, to AmerUs knowledge,
threatened against or with respect to AmerUs or its Subsidiaries in
respect of any material Tax or Tax Asset.
(vi) Neither AmerUs nor any of its Subsidiaries has received
written notice of any proposed or determined Tax deficiency, proposed
reassessment of any property or assessment from any Taxing Authority.
[[Page 13]]
(vii) To the extent that the following action relates to a
material amount of Taxes, neither AmerUs nor any of its Subsidiaries has
since December 31, 2005 (A) made or changed any election concerning any
Taxes, (B) changed an annual accounting period or adopted or changed any
accounting method, (C) settled any Tax claim or assessment, (D) received
a Tax Ruling or entered into an agreement with any Taxing Authority,
(E) filed any amended Tax Returns or (F) surrendered any right to claim
a refund of any Taxes.
(viii) Neither AmerUs nor any of its Subsidiaries has
(A) entered into any transaction that resulted in a material ''deferred
intercompany gain''(within the meaning of Treasury Regulation
Section 1.1502-13) for which such gain, in whole or in part, continues
to be deferred pursuant to the provisions of Treasury
Regulation Section 1.1502-13 as of the date hereof or (B) a material
''excess loss account,''as defined in Treasury
Regulation Section 1.1502-19, in respect of the stock of any Subsidiary
of AmerUs that is a member of the United States affiliated group (as
that term is defined under Code Section 1504(a) and other similar
provisions of state or local Law) that includes AmerUs as a common
parent (''AmerUs Common Group'').
(ix) Neither AmerUs nor any of its Subsidiaries has been a
member of any affiliated group other than the AmerUs Common Group.
(x) Neither AmerUs nor any of its Subsidiaries has engaged in
a trade or business, had a permanent establishment (within the meaning
of an applicable tax treaty or local Law) or has received written notice
of any claim made by a Taxing Authority where AmerUs and its
Subsidiaries, as applicable, do not file a Tax Return that AmerUs or
such Subsidiary is or may be subject to income taxation by that
jurisdiction, and neither AmerUs nor any of its Subsidiaries that are
''U.S. persons,''as that term is defined in Section 7701 of the Code, has
branches in any jurisdiction outside of the United States.
(xi) Within the meaning of Section 355 of the Code, none of
AmerUs or any of its Subsidiaries was a ''distributing corporation''or a
''controlled corporation''in a transaction intended to be governed by
Section 355 of the Code (A) in the two years prior to the date of this
Agreement or (B) in a distribution which could otherwise constitute part
of a ''plan''or ''series of related transactions''in conjunction with the
Merger.
(xii) AmerUs and each of its Subsidiaries has withheld all
material amounts required to have been withheld in connection with
amounts paid or owed to any employee, independent contractor, creditor,
shareholder, policyholder, holder of an Annuity Contract, insured or any
other third party, and such withheld amounts were either duly paid to
the appropriate Taxing Authority or set aside in accounts for such
purpose. AmerUs and each of its Subsidiaries has reported such withheld
amounts to the appropriate Taxing Authority and to each such employee,
independent contractor, creditor, shareholder, policyholder, holder of
an Annuity Contract, insured or any other third party, as required under
Law.
(xiii) AmerUs and its Subsidiaries have prior to the date
hereof, provided to Aviva true and complete copies of all material Tax
Sharing Agreements entered into by AmerUs or any of its Subsidiaries.
[[Page 14]]
(xiv) No asset or liability of AmerUs or of any of its
Subsidiaries is a debt obligation that (A) is a ''registration-required
obligation,''as defined in Section 163(f)(2) of the Code; (B)
constitutes ''corporate acquisition indebtedness''within the meaning of
Section 279(b) of the Code; or (C) is a ''disqualified debt instrument,''as defined in Section 163(l)(2) 163(b)(2) of the Code.
(xv) Neither AmerUs nor any of its Subsidiaries has
participated, within the meaning of Treasury
Regulation Section 1.6011-4(c), or has been a ''material advisor''or
''promoter''(as those terms are defined in Section 6111 and 6112 of the
Code) in (A) any ''reportable transaction''within the meaning of
Sections 6011, 6662A and 6707A of the Code, (B) any ''confidential
corporate tax shelter''within the meaning of Section 6111 of the Code or
(C) any ''potentially abusive tax shelter''within the meaning of
Section 6112 of the Code.
(xvi) With respect to any reinsurance contracts to which
AmerUs or any of its Subsidiaries is a party, to the knowledge of AmerUs
or any of its Subsidiaries no facts, circumstances or basis exists under
which the IRS could make any reallocation, recharacterization or other
adjustment under Section 845(a) of the Code, or make any adjustment
arising from a determination that any reinsurance contract had or has a
significant tax avoidance effect under Section 845(b) of the Code.
(xvii) To the extent within the control of AmerUs and/or its
Subsidiaries (and to the extent not within the control of AmerUs and/or
its Subsidiaries, to their knowledge), any Life Insurance Contract or
Annuity Contract issued, assumed, modified, exchanged, marketed, sold or
administered by an AmerUs Insurer qualifies in all material respects for
the tax treatment described in the associated marketing materials
designed by AmerUs or any of its Subsidiaries, is in compliance in all
material respects with the requirements applicable to AmerUs and its
Subsidiaries, under, as relevant, Code Sections 72, 101, 130, 401, 403,
408, 457, 6047, 7702, 7702A and all other applicable Tax provisions,
including, to the extent applicable, the diversification rules under
Section 817(h), and satisfies all of the investor controls and insurable
interest rules.
''Annuity Contract''means any annuity contract, funding
agreement, guaranteed investment contract or similar contract, including
endorsements, riders and amendments thereto, and forms with respect
thereto.
''Life Insurance Contract''means any life insurance
contract, and any endorsements, riders, amendments and forms with
respect thereto.
''Tax''means (i) all federal, state, local or foreign
taxes, charges, fees, imposts, levies or other assessments, including
all income, gross receipts, capital, sales, use, ad valorem, value
added, transfer, franchise, profits, inventory, capital stock, license,
withholding, payroll, employment, social security, unemployment, excise,
severance, stamp, occupation, premium, property or estimated taxes,
customs duties, fees, assessments or charges of any kind whatsoever,
(ii) all interest, penalties, fines, additions to tax or additional
amounts imposed by any Taxing Authority in connection with any item
described in clause (i), or (iii) any transferee liability in respect of
any items described in clause (i) or (ii) payable by reason of contract,
assumption, [[Page 15]]
transferee liability, operation of law, Treasury
Regulation Section 1.1502-6(a) (or any predecessor or successor thereof
or any analogous or similar provision under Law) or otherwise.
''Tax Asset''means any net operating loss, net capital
loss, investment tax credit, foreign tax credit, charitable deduction,
or any other credit or tax asset that could be carried forward or
carried back to reduce Taxes (including deductions and credits relating
to guaranty fund assessments and the alternative minimum tax).
''Taxing Authority''means the Internal Revenue Service
or any other Governmental Entity responsible for the administration of
any Tax.
''Tax Return''means any return, report or statement
required to be filed with respect to any Tax (including any elections,
declarations, schedules or attachments thereto, and any amendment
thereof) including any information return, claim for refund, amended
return or declaration of estimated Tax, and including, where permitted
or required, combined, consolidated or unitary returns for any group of
entities.
''Tax Sharing Agreement''means any written or unwritten
agreement, indemnity or other arrangement for the allocation or payment
of Tax liabilities or payment for Tax benefits.
(i) Certain Agreements. Except as disclosed in the
AmerUs SEC Documents filed or publicly furnished to the SEC and made
publicly available prior to the date of this Agreement and except for
this Agreement, neither AmerUs nor any of its Subsidiaries is a party to
or bound, as of the date hereof, by any contract, arrangement,
commitment or understanding (i) which is a ''material contract''(as such
term is defined in Item 601(b)(10) of Regulation S-K of the SEC),
(ii) which restricts in any material respect the ability of AmerUs or
any of its Subsidiaries to compete in any line of business, in any
geographic area or with any person, or which requires referrals of
business or requires AmerUs or any of its affiliates to make available
investment opportunities to any person on a priority, equal or exclusive
basis, (iii) with or to a labor union (including any collective
bargaining agreement), or (iv) which would prohibit or delay the
consummation of any of the transactions contemplated by this Agreement.
All contracts, arrangements, commitments or understandings of the type
described in this Section 3.1(i) (collectively referred to herein as the
''AmerUs Contracts'') are valid and in full force and effect,
except to the extent they have previously expired in accordance with
their terms or if the failure to be in full force and effect,
individually or in the aggregate, would not reasonably be expected to
have an AmerUs Material Adverse Effect. AmerUs has made available to
Aviva true and complete copies of all AmerUs Contracts. Neither AmerUs
nor any of its Subsidiaries has, and to the knowledge of AmerUs, none of
the other parties thereto has violated any provision of, or committed or
failed to perform any act, and no event or condition exists, which with
or without notice, lapse of time or both would constitute a default
under the provisions of, any AmerUs Contract, except in each case for
those violations, performance failures and defaults that, individually
or in the aggregate, would not reasonably be expected to have an AmerUs
Material Adverse Effect.
(j) Benefit Plans and Labor Matters. [[Page 16]]
(i) With respect to each material employee benefit plan
(including any ''employee benefit plan''as defined in Section 3(3) of the
Employee Retirement Income Security Act of 1974, as amended (''ERISA''),
including multiemployer plans within the meaning of ERISA Section 3(37)
(''Multiemployer Plans'') and all material equity-based
compensation programs, including stock purchase and stock option plans
and programs, severance, employment, change-in-control, fringe benefit,
collective bargaining, bonus, incentive, deferred compensation, pension
and other material employee benefit plans, agreements, programs,
policies or other arrangements, whether or not subject to ERISA, whether
formal or informal, oral or written (all the foregoing being herein ''AmerUs
Benefit Plans''), (A) under which any employee, agent, director, or
independent contractor or former employee, agent, director, or
independent contractor of AmerUs or any of its Subsidiaries has any
present or future right to benefits, (B) maintained or contributed to by
AmerUs or any of its Subsidiaries or (C) under which AmerUs or any of
its Subsidiaries has any present or future liability other than as
disclosed in the consolidated financial statements of AmerUs included in
its Quarterly Report on Form 10-Q for the quarter ended March 31, 2006,
no event has occurred and, to the knowledge of AmerUs, there exists no
condition or set of circumstances, in connection with which AmerUs or
any of its Subsidiaries could be subject to any material liability,
except for benefit payments in accordance with the terms of the AmerUs
Benefit Plans and this Agreement.
(ii) Section 3.1(j)(ii) of the AmerUs Disclosure Letter
contains a complete listing of all AmerUs Benefit Plans. AmerUs has made
available to Aviva with respect to each AmerUs Benefit Plan true and
complete copies of: (A) the plan documents or agreement (including any
insurance contracts or trust agreements); (B) the summary plan
descriptions and summaries of material modification; (C) Form 5500
reports and, where applicable, audited financial statements and audit
reports for the most recent plan year available and the most recent
financial statement; (D) the most recent actuarial report; (E) for plans
intended to be qualified under Code Section 401(a) a copy of the most
recent IRS determination letter with respect to such qualification; and
(F) employee handbooks, as currently in effect.
(iii) AmerUs and its Subsidiaries, with respect to the AmerUs
Benefit Plans, and the AmerUs Benefit Plans, are in material compliance
with ERISA, the Code (except as currently permitted with respect to
Section 409A under proposed regulations and Internal Revenue Service
guidance with respect thereto) and other applicable Laws.
(iv) No AmerUs Benefit Plan (including any AmerUs Stock Plan)
exists that could result in the payment to any present or former
employee, agent, director or independent contractor of AmerUs or any
Subsidiary of AmerUs of any money or other property or accelerate or
provide any vesting or other rights or benefits to any present or former
employee, agent, director, or independent contractor of AmerUs or any
Subsidiary of AmerUs as a result of the transactions contemplated by
this Agreement, either independently or in connection with any adverse
employment action and irrespective of whether or not such payment would
constitute a parachute payment within the meaning of Code Section 280G.
(v) No AmerUs Benefit Plan is a Multiemployer Plan, and
neither AmerUs nor any of its Subsidiaries has, or could reasonably be
expected to have, any liability under any Multiemployer Plan. [[Page 17]]
(vi) Neither the execution and delivery of this Agreement nor
the consummation of the transactions contemplated hereby will (either
alone or in conjunction with any other event) result in or cause:
(A) the increase, acceleration of timing of payment, funding or vesting
of any benefits under any AmerUs Benefit Plan; (B) the payment or
provision of benefits which are ''excess parachute payments''as the term
is defined in Code Section 280G; or (C) payments or benefits to be
subject to the loss of deductions under Code Section 162(m).
(vii) There are no pending or threatened claims by or on
behalf of, or investigations or governmental audits or requests with
respect to, any AmerUs Benefit Plan (other than routine claims for
benefits).
(viii) Each AmerUs Benefit Plan may be terminated without
incurring a material liability (other than previously accrued benefit
liabilities).
(ix) There are no collective bargaining agreements or other
labor union contracts applicable to any employees of AmerUs or any of
its Subsidiaries.
(x) Section 3.1(j)(x) of the AmerUs Disclosure Letter lists,
as of the date of this Agreement, the number of outstanding Awards,
including with respect to SARs and Units the number of underlying
reference shares of Common Stock that will be converted into Award
Consideration pursuant to Section 2.3.
(k) Subsidiaries. All of the shares of capital stock of each
of the Subsidiaries of AmerUs are owned by AmerUs or by another AmerUs
Subsidiary or Subsidiaries and are (i) fully paid and nonassessable and
(ii) free and clear of any Lien.
(l) Agreements with Regulators. Neither AmerUs nor any
Subsidiary of AmerUs is a party to any written agreement, consent decree
or memorandum of understanding with, or a party to any commitment letter
or similar undertaking to, or is subject to any cease-and-desist or
other order or directive by, or has adopted any policies, procedures or
board resolutions at the request of, any Governmental Entity which
restricts materially the conduct of the business of AmerUs and its
Subsidiaries, taken as a whole, or to the knowledge of AmerUs relates to
AmerUs Insurers capital adequacy or risk management policies, nor has
AmerUs or any Subsidiary of AmerUs been advised in writing by any
Governmental Entity that it is contemplating any such undertakings.
(m) Absence of Certain Changes or Events. Since December 31,
2005, (i) AmerUs and its Subsidiaries have conducted their respective
businesses in the ordinary course consistent with their past practices,
(ii) there has not been any (A) AmerUs Material Adverse Effect, (B) any
declaration, setting aside or payment of any dividend or other
distribution with respect to its capital stock, (C) any split,
combination or reclassification of any of its capital stock or any
issuance or the authorization of any issuance of any other securities in
respect of, in lieu of or in substitution for shares of its capital
stock, (D) any material change in accounting methods, principles or
practices by AmerUs, except for such changes required by changes in SEC
guidelines, GAAP or SAP, (E) any material damage, destruction or other
casualty loss with respect to any material asset or property owned,
leased or otherwise used by AmerUs or any of [[Page 18]]
its Subsidiaries which is not covered by insurance or (F) any material
amendment of any of the AmerUs Benefit Plans.
(n) Board Approval. The Board of Directors of AmerUs, by
resolutions duly adopted by unanimous vote of those voting at a meeting
duly called and held (the ''AmerUs Board Approval''), has
(i) determined that this Agreement and the Merger are fair to and in the
best interests of AmerUs and its shareholders, (ii) approved and adopted
this Agreement and the plan of merger contained herein and
(iii) recommended that shareholders of AmerUs approve each of the
matters constituting the Required AmerUs Vote and directed that such
matter be submitted for consideration by AmerUs shareholders at the
AmerUs Shareholders Meeting, subject to the terms and conditions set
forth herein.
(o) Vote Required. Pursuant to Section 490.1104(5) of the
IBCA, the approval of the holders of Common Stock at a meeting at which
a quorum consisting of at least a majority of the votes entitled to be
cast on the plan of merger exists (the ''Required AmerUs Vote'') is
the only vote of the holders of any class or series of AmerUs capital
stock necessary to approve this Agreement and the transactions
contemplated hereby (including the Merger).
(p) Properties. AmerUs or one or more of its Subsidiaries
(i) has good and marketable title to all the properties and assets
reflected in the latest audited balance sheet included in the AmerUs SEC
Documents as being owned by AmerUs or one or more of its Subsidiaries or
acquired after the date thereof (except properties sold or otherwise
disposed of since the date thereof in the ordinary course of business),
free and clear of all claims, liens, charges, security interests or
encumbrances of any nature whatsoever (''Liens''), except
(A) statutory liens securing payments not yet due, (B) such
imperfections or irregularities of title, claims, liens, charges,
security interests or encumbrances as do not affect the use of the
properties or assets subject thereto or affected thereby or otherwise
impair business operations at such properties, other than, in each case,
which individually or in the aggregate, would not reasonably be expected
to have an AmerUs Material Adverse Effect and (C) zoning and building
codes and other applicable Laws regulating the use, development and
occupancy of real property and permits consents and rules under such
Laws that do not materially affect the use, development and occupancy of
such real property or otherwise impair the business operations at such
property and (ii) is the lessee of all leasehold estates reflected in
the latest audited balance sheet included in the AmerUs SEC Documents as
being leased by AmerUs or one or more of its Subsidiaries or leased
after the date thereof (except for leases that have expired by their
terms since the date thereof) and is in possession of the properties
purported to be leased thereunder, and each such lease is valid without
default thereunder by the lessee or, to the knowledge of AmerUs, the
lessor other than, in each case, which individually or in the aggregate,
would not reasonably be expected to have an AmerUs Material Adverse
Effect.
(q) Intellectual Property.
(i) AmerUs and its Subsidiaries own, or have valid and
enforceable licenses to use, all trademarks, service marks, trade names
and designs (including any registrations or applications for
registration, as well as common law rights in any of the foregoing),
together with all goodwill related to the foregoing, patents (including
any continuations, continuations in part, renewals and applications for
any of the foregoing) and inventions, copyrights (including any [[Page 19]]
registrations and applications therefor and whether registered or
unregistered), Internet domain names, computer software, databases,
works of authorship, mask works, technology, trade secrets and other
confidential information, know-how, proprietary processes, formulae,
algorithms, models, user interfaces, inventions, discoveries, concepts,
ideas, techniques, methods, source codes, object codes, methodologies
and, with respect to all of the foregoing, related confidential data or
information (collectively, the ''AmerUs Intellectual Property''),
which in each case necessary for the conduct of their respective
business as conducted on the date hereof, except where such failures to
own or possess valid, subsisting and enforceable licenses to use such
AmerUs Intellectual Property, either individually or in the aggregate,
would not reasonably be expected to have an AmerUs Material Adverse
Effect. Neither AmerUs nor any of its Subsidiaries has received any
written notice of infringement or conflict with, and to AmerUs
knowledge, there are no infringements of or conflicts with, the rights
of any third party with respect to the use or ownership of any AmerUs
Intellectual Property by AmerUs and its Subsidiaries that, in either
case, individually or in the aggregate, would reasonably be expected to
have an AmerUs Material Adverse Effect. To the knowledge of AmerUs, all
AmerUs Intellectual Property that has been licensed by AmerUs or any of
its Subsidiaries from third parties is being used substantially in
accordance with the applicable license (as amended) pursuant to which
AmerUs or such Subsidiary acquired the right to use such AmerUs
Intellectual Property, except where such uses, either individually or in
the aggregate, would not reasonably be expected to have an AmerUs
Material Adverse Effect.
(ii) AmerUs and its Subsidiaries have established and are in
compliance with commercially reasonable security programs that are
designed to protect (A) the security, confidentiality and integrity of
transactions executed through their computer systems, including security
protocols and techniques when appropriate, and (B) the security,
confidentiality and integrity of all confidential or proprietary data
except, in each case, which individually or in the aggregate would not
reasonably be expected to have an AmerUs Material Adverse Effect.
Neither AmerUs nor any of its Subsidiaries has suffered a material
security breach with respect to their data or systems, and neither
AmerUs nor any of its Subsidiaries has notified consumers or employees
of any such information security breach.
(r) Brokers or Finders. Other than Goldman Sachs & Co., no
agent, broker, lawyer, investment banker, financial advisor or other
firm or person is or will be entitled to any brokers or finders fee or
any other similar commission or fee in connection with any of the
transactions contemplated by this Agreement.
(s) Opinion of AmerUs Financial Advisor. AmerUs has received
the written opinion of its financial advisor, Goldman Sachs & Co., dated
the date of this Agreement, to the effect that, as of the date hereof,
the Per Share Amount to be paid by Aviva to the AmerUs shareholders
pursuant to Section 2.1(a) is fair, from a financial point of view, to
the holders of Common Stock.
(t) Takeover Laws. None of the business combination
provisions of Section 490.1110 of the IBCA or any similar provisions of
the IBCA, Amended and Restated Articles of Incorporation or Amended and
Restated Bylaws of AmerUs are applicable to the transactions
contemplated by this Agreement because such provisions do not apply by
their terms or because any required approvals of the Board of Directors
of AmerUs have been obtained. [[Page 20]]
(u) Information Supplied.
(i) The Proxy Statement will comply as to form in all material
respects with the requirements of the Exchange Act and applicable rules
thereunder. The Proxy Statement and in the notice of the meeting
pursuant to Section 490.1104 of the IBCA to the holders of Common Stock
(the ''Notice of AmerUs Shareholders Meeting''), will not, at the
date mailed to the holders of Common Stock or at the time of the AmerUs
Shareholders Meeting, contain any untrue statements of a material fact
or omit to state any material fact required to be stated therein or
necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading.
(ii) Notwithstanding the foregoing provisions of this
Section 3.1(u), no representation or warranty is made by AmerUs with
respect to statements made or incorporated by reference in the Proxy
Statement based on information supplied in writing by or on behalf of
Aviva for inclusion or incorporation by reference therein.
(v) Certain Securities Matters.
(i) Each AmerUs Broker-Dealer and AmerUs Adviser possesses all
licenses and registrations necessary to conduct its business and is
current in all material filings required by the SEC or any other
Governmental Entity, and is and has been since December 31, 2003 in full
compliance with all applicable Laws, except for any failures to possess
such licenses and register or comply which would not, individually or in
the aggregate, reasonably be expected to have an AmerUs Material Adverse
Effect. Each AmerUs Broker-Dealer is a member in good standing of the
NASD and such other organizations in which its membership is required in
order to conduct its business as now conducted, except such failures
which would not, individually or in the aggregate, reasonably be
expected to have an AmerUs Material Adverse Effect.
(ii) There is (A) no AmerUs Subsidiary, (B) no separate
account of any AmerUs Insurer, (C) no ''affiliated person''(within the
meaning of the Investment Company Act of 1940, and the rules and
regulations of the SEC promulgated thereunder (the ''Investment
Company Act'')) nor (D) any AmerUs Fund, AmerUs Private Fund or any
portfolio thereof that is required to be registered with the SEC under
the Investment Company Act.
(iii) No AmerUs Adviser nor, to the knowledge of AmerUs, any
''person associated''(within the meaning of the Investment Advisers Act
of 1940, as amended, and the rules and regulations of the SEC
promulgated thereunder (the ''Investment Advisers Act'')) thereof,
with an AmerUs Adviser is ineligible pursuant to Section 203(e) of the
Investment Advisers Act to serve as an investment adviser or as a person
associated with an AmerUs Adviser to a registered investment adviser. No
AmerUs Broker-Dealer nor, to the knowledge of AmerUs, any ''associated
person''(within the meaning of the Exchange Act) thereof, is ineligible
pursuant to Section 15(b) of the Exchange Act to serve as a
broker-dealer or as an associated person to a registered broker-dealer.
The following terms shall have the meanings set forth below: [[Page 21]]
''AmerUs Adviser''shall mean any AmerUs Subsidiary that
conducts activities of an investment adviser as such term is defined in
Section 2(a)(20) of the Investment Company Act and Section 202(a)(11) of
the Investment Advisers Act.
''AmerUs Broker-Dealer''shall mean any AmerUs Subsidiary
that conducts activities of a broker or dealer, as such terms are
defined in Section 3(a) of the Exchange Act.
''AmerUs Fund''shall mean any management investment
company, as defined under the Investment Company Act, organized by an
AmerUs Adviser or interests in which are offered by AmerUs or its
affiliates or any portfolio thereof that is registered or required to be
registered as an investment company with the SEC and for which any
AmerUs Adviser acts as an investment adviser or sub-adviser.
''AmerUs Private Fund''shall mean any collective
investment entity organized by an AmerUs Adviser or interests in which
are offered by AmerUs or its affiliates, other than an AmerUs Fund that
is not required to be registered as an investment company with the SEC
and for which any AmerUs Adviser acts as an investment adviser or
sub-adviser.
''AmerUs Insurer''shall mean each AmerUs Subsidiary that
issues insurance policies.
(w) Insurance Reports.
(i) Each AmerUs Insurer is listed in Section 3.1(w) of the
AmerUs Disclosure Letter. Each of the AmerUs Insurers has filed all
annual and quarterly statements, together with all exhibits,
interrogatories, notes, schedules and any actuarial opinions,
affirmations or certifications or other supporting documents in
connection therewith, required to be filed with or submitted to the
appropriate insurance regulatory authorities of the jurisdiction in
which it is domiciled or commercially domiciled on forms prescribed or
permitted by such authority (collectively, the ''AmerUs SAP Statements''),
except for such failures to file that, individually or in the aggregate,
would not reasonably be expected to have an AmerUs Material Adverse
Effect. AmerUs has delivered or made available to Aviva, to the extent
permitted by applicable Laws, copies of all annual AmerUs SAP Statements
for each AmerUs Insurer for the periods beginning January 1, 2004 and
through the date hereof and the quarterly AmerUs SAP Statements for each
AmerUs Insurer for the quarterly period ended March 31, 2006, each in
the form (including exhibits, annexes and any amendments thereto) filed
with the applicable state domiciliary insurance regulatory authority and
true and complete copies of all financial examination reports of
insurance departments and any insurance regulatory authorities received
by AmerUs on or after January 1, 2004 and through the date hereof
relating to AmerUs Insurers. Financial statements included in the AmerUs
SAP Statements were prepared in conformity SAP and present fairly in all
material respects the statutory financial position of the relevant
AmerUs Insurer as at the respective dates thereof and the results of
operations of such AmerUs Insurer for the respective periods then ended.
The AmerUs SAP Statements complied in all material respects with all
applicable Laws when filed, and no material deficiency has been asserted
in writing by any Governmental Entity with respect to any AmerUs SAP
Statements which has not been cured. The annual statutory balance sheets
and income statements included in the AmerUs SAP Statements have been
audited by AmerUs independent auditors, and AmerUs has delivered [[Page 22]]
or made available to Aviva true and complete copies of all audit
opinions related thereto for periods beginning January 1, 2004.
(ii) The policy reserves of the AmerUs Insurers recorded in
their respective AmerUs SAP Statements, as of their respective dates
since July 1, 2004: (A) have been computed in all material respects in
accordance with presently accepted actuarial standards consistently
applied as in effect on their respective dates; (B) have been based on
actuarial assumptions that are consistent in all material respects with
applicable contract provisions; (C) met the requirements of applicable
Law in all material respects; and (D) were computed on the basis of
actuarial assumptions and actuarial methods consistent in all material
respects with those used to compute the corresponding items in the
AmerUs SAP Statements; provided, however, that it is acknowledged and
agreed that AmerUs is not making any representation or warranty in this
Section 3.1(w)(ii) as to the adequacy or sufficiency of such reserves.
(x) Insurance Business.
(i) All policies, binders, slips,
certificates, guaranteed insurance contracts, annuity contracts and
participation agreements and other agreements of insurance, whether
individual or group, in effect as of the date hereof (including all
applications, supplements, endorsements, riders and ancillary documents
issued in connection therewith) that are issued by an AmerUs Insurer
(collectively, the ''AmerUs Insurance Contracts''), to the extent
required under applicable Laws, on forms and at rates approved by the
insurance regulatory authority of the jurisdiction where issued or, to
the extent required by applicable Laws, have been filed with and not
objected to by such authority within the period provided for objection,
except as, individually or in the aggregate, would not reasonably be
expected to have an AmerUs Material Adverse Effect.
(ii) A true and complete copy of the Actuarial Appraisal of
Insurance Operations of AmerUs as of September 30, 2005, including all
amendments, supplements, errata and annexes thereto (the ''AmerUs
Actuarial Analysis'') has been made available to Aviva prior to the
date hereof. The information and data furnished by AmerUs or any AmerUs
Insurer to its independent actuaries in connection with the preparation
of the AmerUs Actuarial Analysis were, to the knowledge of AmerUs,
accurate in all material respects for the periods covered in the AmerUs
Actuarial Analysis.
(iii) AmerUs has made available to Aviva true and complete
copies of (A) all policy and contract forms filed in the domiciliary
state of the AmerUs Insurer issuing the policy relating to any annuity
or universal life insurance contract offering equity indexed or total
return accounts issued by the AmerUs Insurers (the ''EI Products'')
and all forms of sales brochures, sales literature and advertising
materials, developed by an AmerUs Insurer for EI Products, each to the
extent utilized by an AmerUs Insurer during the period beginning
January 1, 2004 through the date of this Agreement and (B) all material
reports, written correspondence and written communications received from
an AmerUs Insurer or sent to an AmerUs Insurer by any Governmental
Entity relating to any material examinations or investigations by any
Governmental Entity regarding any EI Product. AmerUs has received no
written notice from any Governmental Entity of any material pending
examinations, inspections or investigations, or alleging any material
violation of applicable securities Law, by any Governmental Entity
regarding any EI Product as of the date of this Agreement, and to the
knowledge of AmerUs, [[Page 23]]
there are no such pending or threatened examinations, inspections or
investigations as of the date of this Agreement.
(iii) AmerUs has made available to Aviva a true and complete
copy of its product analysis letter, including all annexes and exhibits
(but excluding the list of largest sellers), as further described in
Section 3.1(x)(iv) of the AmerUs Disclosure Letter (the ''Product
Letter''). The description of the products and marketing programs in
the Product Letter are fair summaries in all material respects of the EI
Products that are annuities and the related marketing programs described
therein and, as of the date hereof, AmerUs has no actual knowledge of
any other documents, events or circumstances which could reasonably be
expected to cause AmerUs analysis of the regulatory status of such
products described therein to be materially different from AmerUs
analysis contained therein.
(y) Risk Management Instruments. Since December 31, 2005,
all derivative instruments, including, interest rate swaps, caps, floors
and option agreements, entered into by AmerUs or its Subsidiaries, were
entered into in conformity in all material respects with AmerUs written
investment policies in effect at the time any such derivative instrument
was entered into.
(z) Producer Sales and Marketing.
(i) From and after January 1, 2004 (A) each employee of AmerUs
and its Subsidiaries, agent, manager, intermediary, broker,
broker-dealer, third-party administrator, independent marketing
organization (affiliated and unaffiliated), producer, financial
institution, registered representative, consultant, advisor, call center
personnel, or distributor required to be licensed as a Producer in any
state (each, a ''Producer'') who marketed, sold, serviced, managed,
advised or administered with holders of the products issued by AmerUs
and its Subsidiaries (''Transacted''), at the time such Producer
Transacted business for AmerUs or the relevant Subsidiary, was duly
appointed by AmerUs or the relevant Subsidiary to act as a Producer and,
to the knowledge of AmerUs, was duly licensed or registered as a
Producer, in each case, in the particular jurisdiction in which such
Producer, placed, serviced, managed, advised or administered such
business; (B) there have been no violations by Producers of any Law in
connection with the marketing or sale of products issued by AmerUs and
its Subsidiaries; (C) all compensation paid to each such Producer was
paid in accordance with applicable Law; and (D) all training and
instruction manuals pertaining to the sale of the products by AmerUs and
its Subsidiaries provided to each such Producer by AmerUs and its
Subsidiaries were in compliance with all applicable Laws; except for, in
the case of clauses (A), (B), (C), or (D), such failures to appoint or
failures to be licensed (in the case of clause A), violations (in the
case of clause B), and failures to comply with applicable Law (in the
cases of clauses C and D) that, individually or in the aggregate, would
not reasonably be expected to have an AmerUs Material Adverse Effect,
and provided that the representations in clauses (A), (B), (C) and
(D) are made to the actual knowledge of AmerUs with respect to any
Producer that is not an employee of AmerUs or its Subsidiaries.
(aa) Reinsurance. With respect to any ceded reinsurance or
coinsurance agreement of any AmerUs Insurer which either is in force or
has outstanding reinsurance recoverables (''AmerUs Reinsurance
Agreements''), except as would not, individually or in the aggregate,
[[Page 24]]
reasonably be expected to have an AmerUs Material Adverse Effect, each
AmerUs Insurer has appropriately taken credit for, outstanding
reinsurance recoverables under the AmerUs Reinsurance Agreements in any
(i) AmerUs SAP Statements and (ii) AmerUs SEC Documents. All AmerUs
Reinsurance Agreements are valid and in full force and effect, except to
the extent they have previously expired in accordance with their terms
or the failure to be valid and in full force and effect, individually or
in the aggregate, would not reasonably be expected to have an AmerUs
Material Adverse Effect. Neither AmerUs nor any AmerUs Insurer, nor to
the knowledge of AmerUs, any other party to an AmerUs Reinsurance
Agreement is in default as to any provision thereof, and, to the
knowledge of AmerUs, no condition exists that, with or without notice or
lapse of time or both, would constitute a default thereunder, except for
any such default or condition as would not, individually or in the
aggregate, reasonably be expected to have an AmerUs Material Adverse
Effect.
3.2. Representations and Warranties of Aviva and Merger Sub.
Aviva and Merger Sub jointly represent and warrant to AmerUs as follows:
(a) Organization, Standing and Power.
(i) Each of Aviva and Merger Sub is a corporation duly
organized and validly existing under the Laws of its jurisdiction of
incorporation or organization, has all requisite corporate power and
authority to own, lease and operate its properties and to carry on its
business as now being conducted, and is duly qualified to do business in
each jurisdiction in which the nature of its business or the ownership
or leasing of its properties makes such qualification necessary, other
than in such jurisdictions where the failure to so qualify would not,
either individually or in the aggregate, reasonably be expected to have
a material adverse effect on the ability of Aviva or Merger Sub to
perform their respective obligations under this Agreement (an ''Aviva
Material Adverse Effect'').
(ii) Aviva has previously made available to AmerUs true,
complete and correct copies of the organizational documents of Aviva as
of December 31, 2005, which are in full force and effect and have not
been amended or otherwise modified.
(b) Authority.
(i) Each of Aviva and Merger Sub has all requisite
corporate power and authority to enter into this Agreement and to
consummate the transactions contemplated hereby. The execution and
delivery of this Agreement and the consummation of the transactions
contemplated hereby have been duly authorized by all necessary corporate
action on the part of Aviva and Merger Sub (including Aviva or a wholly
owned Subsidiary of Aviva in its capacity as the sole shareholder of
Merger Sub) and no other corporate or shareholder proceedings on the
part of Aviva or Merger Sub are necessary to authorize this Agreement
and consummate the transactions contemplated hereby. This Agreement has
been duly executed and delivered by Aviva and Merger Sub and (assuming
the due authorization, execution and delivery by AmerUs) constitutes a
valid and binding obligation of each of Aviva and Merger Sub,
enforceable against each of Aviva and Merger Sub in accordance with its
terms, except to the extent the enforcement is limited by bankruptcy,
insolvency, fraudulent transfer, reorganization, moratorium and similar
[[Page 25]]
Laws of general applicability relating to or affecting creditors rights
and to general equitable principles.
(ii) The execution and delivery of this Agreement by each of
Aviva and Merger Sub do not, and the performance of its respective
obligations and consummation of the transactions contemplated hereby
will not, (A) result in any Violation pursuant to any provision of the
organizational documents of Aviva or Merger Sub or (B) subject to
obtaining or making the consents, approvals, orders, authorizations,
registrations, declarations and filings referred to in subsection (iii)
below, result in any Violation of any loan or credit agreement, note,
mortgage, indenture, lease, or other agreement, obligation, instrument,
permit, concession, franchise, license, or Law applicable to Aviva or
Merger Sub or their respective properties or assets, which Violation, in
the case of clause (B), either individually or in the aggregate, would
reasonably be expected to have an Aviva Material Adverse Effect.
(iii) No consent, approval, order or authorization of, or
registration, declaration or filing with, any Governmental Entity is
required to be filed or obtained by Aviva or Merger Sub in connection
with the execut |